Steroid Regimen After Cataract Surgery
Use topical prednisolone acetate 1% (or equivalent topical corticosteroid) as the standard postoperative steroid regimen after uncomplicated cataract surgery, typically tapered over 2-4 weeks. This remains the gold standard with the most established safety and efficacy profile 1.
Standard Topical Steroid Approach
The traditional regimen consists of:
- Topical corticosteroid (prednisolone acetate 1% or equivalent)
- Topical NSAID (reduces early cystoid macular edema risk) 1
- Intracameral antibiotic at time of surgery (reduces endophthalmitis risk) 1
The 2022 AAO Preferred Practice Pattern emphasizes that topical NSAIDs reduce early postoperative CME incidence, though long-term benefit hasn't been demonstrated 1. This guideline framework supports combination anti-inflammatory therapy rather than steroids alone.
Alternative "Dropless" Options: Proceed with Caution
Recent research has explored sustained-release steroid alternatives, but the evidence shows important nuances:
Intracanalicular Dexamethasone Insert (DII)
- Higher breakthrough inflammation rate (9.0% vs 3.1%) compared to standard topical prednisolone 2
- Similar CME rates (4.9% vs 4.3%) 2
- No IOP elevation concerns 2
- May be acceptable for patients with severe compliance issues, but recognize the increased inflammation risk
A more recent 2026 study showed comparable outcomes when DII was combined with topical ketorolac (2.0% breakthrough inflammation in both groups), suggesting the combination with NSAID may be critical 3.
Intracameral Dexamethasone 9% Suspension
- Demonstrated equivalent efficacy and safety to standard topical regimen in a 2025 contralateral eye study 4
- No difference in inflammation scores by day 7 postoperatively 4
- No IOP elevation or endothelial cell loss 4
- This represents the most promising dropless alternative based on recent high-quality evidence
Intravitreal Triamcinolone-Moxifloxacin
- Significantly higher IOP at 1 month (15.64 mmHg vs 14.16 mmHg with intracameral dexamethasone) 5
- More anterior chamber inflammation on postoperative day 1 compared to intracameral dexamethasone 5
- Less favorable risk profile; avoid this approach
Key Clinical Considerations
Standard vs "Soft" Steroids: A 2024 meta-analysis found no clinically meaningful difference between standard potency steroids (prednisolone acetate, dexamethasone) and softer steroids (fluorometholone, loteprednol), except for slightly lower AC flare at day 7 with standard steroids 6. Both produce comparable inflammation control and IOP effects 6.
Common Pitfalls to Avoid:
- Don't use intravitreal triamcinolone due to IOP elevation risk 5
- If using DII alone without topical NSAID, expect higher breakthrough inflammation rates 2
- Don't assume all dropless options are equivalent—intracameral dexamethasone 9% has better evidence than DII 4, 2
Algorithmic Approach
For routine uncomplicated cataract surgery:
- First-line: Topical prednisolone acetate 1% (tapered over 2-4 weeks) + topical NSAID + intracameral antibiotic at surgery
- Alternative for compliance concerns: Intracameral dexamethasone 9% suspension placed in capsular bag + topical NSAID + intracameral antibiotic
- Avoid: Intravitreal triamcinolone (IOP risk), DII monotherapy without NSAID (higher inflammation)
For high-risk patients (diabetes, epiretinal membrane, uveitis history): Maintain topical steroid regimen as standard; dropless alternatives have insufficient data in this population.